Gedeon Richter’s sales in Romania rose 1.4% to EUR131.4 million in 2012, from EUR129.6 million in 2011, backed by wholesale and retail operations, the company said in a report released early February this year.
The Romanian subsidiaries accounted for 70% of Gedeon Richter’s turnover in the wholesale and retail segment, namely EUR112.2 million (around RON500 million). The sales growth in Romania was 7.3% in Romanian lei and 2.2% in euro on the year in 2012, according to the report.
On the medicine production segment, the company’s sales in Romania rose 0.6% to EUR31.3 million in 2012. Computed in Romanian lei, the sales growth was 5.8% to RON139.4 million. On the segment of female healthcare products, sales in Romania fell 2.7% to EUR7.3 million.
In 2012, Gedeon Richter paid RON14.3 million (EUR3.2 million) to Romania’s state budget for the claw-back,
In Romania, Gedeon Richter runs a pharmaceuticals company with the same name, wholesaler Pharmapharm and Gedeon Richter Farmacia with a network of over 120 drug stores.
In 2012, Gedeon Richter group reported 2.8% higher overall sales, to EUR1.13 billion, while its net profit was flat at EUR176 million.
Gedeon Richter will open a pharmaceutical factory in Ukraine in the upcoming period.